Specifications tableSubjectSurgerySpecific subject areaRenal cancer surgery. Partial nephrectomy. Renal warm ischemia.Type of dataTableFigureGraphHow data were acquiredBiochemistry kits: urea (Urea UV, REF 104--4 / 50, Lote 7013, Labtest, Lagoa Santa, Brazil) and creatinine (Creatinina K, REF 96--300, Lote 7013, Labtest). Apparatus: semiautomatic biochemical analyser (Bioplus BIO-2000, Barueri, Brazil), precision scale (Marte AD2000, São Paulo, Brazil), Axiocam 506 color (Carl Zeiss Microscopy, LLC, Jena, Germany) attached to the Stereo Discovery.V8 stereoscope (Carl Zeiss) and light microscope (Olympus BX51, Tokyo, Japan) equipped with a digital camera (Olympus DP71, Tokyo, Japan).Softwares: Zaiss Axiocam for Windows, Olympus Cam for Windows, Microsoft Excel 2016, Image J for Windows and GraphPad Prism 8.3.1 for Windows.Data formatRawAnalysedParameters for data collectionThe Wistar rats used were all male, clinically healthy, with an average weight of 320 g and 9 weeks of age. They were kept in polypropylene boxes with a maximum number of 3 animals/box, in a vivarium environment with light/dark cycle and were offered water and commercial feed ad libitum. They were divided into four groups at random. The treatment of animals in the Untreated (S and I) and Treated (SR and IR) groups was conducted in a standardized manner, and the same can be said for surgical procedures, euthanasia, blood collection and analysis of urea and creatinine, dissection and kidney collection, weighing, volume measurement, cleavage, buffered formalin fixation, Cavalieri method slice analysis for the cortex-non-cortex areas ratio (C---NC), histological processing, histological slide making and stain, drying, random photomicrographs, glomerular volumetric density (Vv \[Glom\]) and volume-weighted mean glomerular volume (VWGV) analysis, data tabulation and statistical analysis. P-value was always considered significant when \<0.05.Description of data collectionDuring each animal\'s anesthetic plan, a cardiac puncture was performed to collect blood, which was subsequently centrifuged to obtain the serum and thus, the serum urea and creatinine dosage by a semiautomatic biochemical analyser. The abdominal cavity was then opened to access the kidneys, which were dissected, collected and weighed. The renal volume was measured by the Scherle\'s method, which is used to determine the volume of bodies with anirregular surface based on the Archimedes principle, that is, a body totally or partially immersed in a fluid undergoes a thrust that is equal to the weight of the volume of the fluid displaced by the body. To measure it, the weight (W) is recorded to be given by the displacement of an isotonic saline solution by the organ volume. As the density (σ) of the isotonic saline solution is 1.0048 and the volume (V) is obtained by the formula: *V* = *W*/σ, the volume value is like the weight (*V* ≈ *W*). The kidneys were cleaved transversely in the hilar region and fixed in separate flasks containing 3.7% buffered formalin solution. Isotropic, uniform and random fragments of the kidneys were obtained using the vertical cleavage method. The latter were routinely processed for histology in a processor with dehydration by ethyl alcohol baths in increasing concentrations, followed by clarification in xylol and, finally, embedded and embedded in paraffin in the apparatus. After slicing 5 μm thick slices through the microtomy and making slides. After drying, the slides were stained by the haematoxylin and eosin method for histopathological and stereological Vv\[Glom\] and VWGV. The proportional area of the cortex and non-cortex regions (medulla, capsule and adipose tissue of the renal sinus) was calculated using Cavalieri\'s method using the ImageJ software. The kidneys were sectioned into seven to eight transverse slices 2 mm thick and a transvesal surface of each slice was photographed in a camera attached to the stereomicroscope, along with a ruler millimeter for further calibration of ImageJ. The images were analysed under 15x magnification. First, the distance occupied by a specified number of pixels of the image in millimeters is calibrated using the ruler. After calibration, the total area of the slice and the area of the non-cortical region in each image were firstly analysed using the "Polygon selections" tool and, through subtraction, it was possible to calculate the area of the cortical region. Multiplying the value obtained by the volume obtained by the Scherle method, it was possible to calculate the volume of each region, cortical (CV) and non-cortical. Vv \[Glom\] is given by Pp/Pt, where Pp is the number of points that overlap the glomeruli and Pt is the total number of points in the grid (42). The Vv is given in percentage and, multiplying this value by the VC and dividing the result by 100, the numerical value of the absolute glomerular density is found in milliliters. The VWGV was estimated using the point interception method. Over the length of the glomerulus intercepted by the line of a grid with lines parallel to each other, a logarithmic ruler of 32 mm in length is placed, composed of a series of 15 classes. This grid is placed over the image at randomly selected angles, with the angle being recalculated, at random, for each image analysed (ranging from 5° to 90°, with 5° intervals). The number of glomeruli per cubic millimeter of renal cortex (N \[Glom\]) was calculated using the formula VCxVv \[Glom\]/VWGV.Data source locationInstitution: State University of Rio de JaneiroCity/Town/Region: Rio de JaneiroCountry: BrazilData accessibilityWith the articleRelated research articleBuys-Gonçalves GF, Sampaio FJB, Silva MEM, Pereira-Sampaio MA, De Souza DB. Histomorphometric evaluation of the rat kidney submitted to warm ischemia and the protective effect of resveratrol. Am J Surg. 2020; doi:[10.1016/j.amjsurg.2020.02](https://doi.org/10.1016/j.amjsurg.2020.02){#interref0002b}. In press.

Value of the data {#sec0001a}
=================

•These data bring positive parameters and evidence regarding the nephroprotective effect of resveratrol related to warm ischemia in Wistar rats, an experimental model widely used in preclinical trials•Such data may be beneficial for researchers who wish to justify studies involving the protective effects of resveratrol against renal or oxidative ischemic damage more generally. Thus, urologists and nephrologists who wish to research and/or use this bioflavonoid as a complementary treatment for their patients who will undergo partial nephrectomy can also benefit•Scholars with lines of research involving bioflavonoids, or specifically resveratrol, can use this data and methodology to carry out related research, since they can be used as a complement and reference•The present data demonstrate that resveratrol protects the kidney against damage from warm ischemia in a quantitative, that is, absolute way. This is because the number of glomeruli per kidney is very close to the number of remaining nephrons

1. Data description {#sec0001}
===================

The present dataset describes the levels of serum biochemical markers, as well as morphometric and stereological analysis of rat kidneys submitted to 1-hour arteriovenous ischemia treated previously with resveratrol. [Fig. 1](#fig0001){ref-type="fig"} demonstrates the experimental and analytical steps that were conducted to obtain serum biochemical data for urea and creatinine. [Fig. 2](#fig0002){ref-type="fig"} demonstrates the experimental and analytical steps that were conducted to obtain the morphometric and stereological data, as well as their analysis. [Fig. 3](#fig0003){ref-type="fig"} describes the calculations to obtain specific data so that it was possible to calculate the N\[G*lom*\]. [Fig. 4](#fig0004){ref-type="fig"} scatter chart representing C---NC raw data from different groups' animals; transversal black midline represents group\'s mean. [Fig. 5](#fig0005){ref-type="fig"} grouped column chart representing left renal volume and cortical volume averages of experimental groups; means are shown above the graph\'s bars. [Fig. 6](#fig0006){ref-type="fig"} scatter chart representing Vv\[Glom\] raw data from different groups' animals; transversal black midline represents group\'s mean. [Fig. 7](#fig0007){ref-type="fig"} scatter chart representing N\[Glom\] raw data from different groups' animals; transversal black midline represents group\'s mean. [Table 1](#tbl0001){ref-type="table"} shows raw data of serum urea and creatinine of rats submitted to sham surgery or to left renal warm ischemia with or without resveratrol treatment. [Table 2](#tbl0002){ref-type="table"} contains raw data of animals' body weight, renal weight and volume of experimental groups. [Table 3](#tbl0003){ref-type="table"} includes raw data of kidney morphological data of rats submitted to sham surgery or to left renal warm ischemia with or without resveratrol treatment.Fig. 1How was the biochemical data obtained?.Fig. 1Fig. 2How was the morphometric data obtained?.Fig. 2Fig. 3Calculations Used.Fig. 3Fig. 4Cortex-non-cortex areas ration.Fig. 4Fig. 5Average Left Renal Volume and Cortical Volume.Fig. 5Fig. 6Glomerular Volumetric Density.Fig. 6Fig. 7Number of Glomeruli per Kidney.Fig. 7Table 1Raw data: serum urea and creatinine of rats submitted to sham surgery or to left renal warm ischemia with or without resveratrol treatment.Table 1Sham groupSerum urea (mg/dL)Serum creatinine (mg/dL)Ischemia groupSerum urea (mg/dL)Serum creatinine (mg/dL)Animal S1420.46Animal I1430.42Animal S2410.44Animal I2500.44Animal S3400.44Animal I3440.45Animal S4420.45Animal I4400.51Animal S5410.42Animal I5430.50Animal S6430.45Animal I6500.51Animal S7390.45Animal I7510.46Animal S8410.42Animal I8450.50Animal S9450.44Animal I9440.45Animal S10410.45Animal I10480.50  Sham Resveratrol groupSerum urea (mg/dL)Serum creatinine (mg/dL)Ischemia Resveratrol groupSerum urea (mg/dL)Serum creatinine (mg/dL)Animal SR1460.46Animal IR1490.46Animal SR2450.45Animal IR2420.53Animal SR3470.50Animal IR3430.49Animal SR4460.50Animal IR4430.51Animal SR5480.43Animal IR5450.43Animal SR6390.44Animal IR6420.50Animal SR7430.49Animal IR7440.49Animal SR8440.43Animal IR8420.44Animal SR9450.45Animal IR9400.39Animal IR10430.40Table 2Raw data: body weight, renal weight and volume of experimental groups.Table 2Animals from Sham groupBody weight (g)Left kidney weight (g)Left kidney volume (ml)Right kidney weight (g)Right kidney volume (ml)Animal S1298.00.930.911.081.04Animal S2301.01.051.011.111.08Animal S3278.51.000.981.091.05Animal S4291.51.011.001.010.99Animal S5368.51.111.071.131.10Animal S6299.00.900.880.950.93Animal S7329.51.041.000.970.93Animal S8357.51.201.171.131.11Animal S9369.01.171.191.281.29Animal S10346.51.411.371.321.31  Animals from Ischemia groupBody weight (g)Left kidney weight (g)Left kidney volume (ml)Right kidney weight (g)Right kidney volume (ml)Animal I1300.01.051.011.011.00Animal I2361.01.371.341.241.22Animal I3295.00.850.900.950.94Animal I4362.51.551.311.361.37Animal I5339.01.321.251.361.32Animal I6292.01.001.050.940.96Animal I7295.01.181.200.991.02Animal I8342.01.371.311.291.29Animal I9328.01.351.261.031.31Animal I10356.01.241.181.401.38  Animals from Sham Resveratrol groupBody weight (g)Left kidney weight (g)Left kidney volume (ml)Right kidney weight (g)Right kidney volume (ml)Animal SR1384.51.121.141.161.17Animal SR2376.01.141.151.251.23Animal SR3348.01.141.081.281.28Animal SR4353.01.121.051.111.09Animal SR5363.01.231.251.341.33Animal SR6298.01.031.041.121.11Animal SR7334.01.211.211.191.20Animal SR8348.51.501.501.371.37Animal SR9368.01.541.501.521.46  Animals from Ischemia Resveratrol groupBody weight (g)Left kidney weight (g)Left kidney volume (ml)Right kidney weight (g)Right kidney volume (ml)Animal IR1276.50.890.990.800.81Animal IR2369.51.121.121.111.22Animal IR3337.01.191.311.101.10Animal IR4302.51.041.040.980.98Animal IR5278.00.920.930.750.74Animal IR6323.51.311.311.161.17Animal IR7350.51.151.151.341.39Animal IR8331.01.271.231.171.13Animal IR9324.51.251.201.251.23Animal IR10290.51.050.991.050.98Table 3Raw data: Kidney morphological data of rats submitted to sham surgery or to left renal warm ischemia with or without resveratrol treatment.Table 3Sham groupC-NC RatioCortical Volume (ml)Vv\[Glom\] (%)Total glomerular volume (µm³)VWGV (µm³)N\[Glom\] (millions per kidney)Animal S10.769120.699905.8142840,694,579,7561,887,222.21421,563.21574Animal S20.715230.722386.0952344,031,304,1471,388,244.61331,717.25194Animal S30.774670.759185.9523845,189,604,6841,477,171.31430,591.98636Animal S40.781910.781915.7238044,755,106,9531,635,263.22727,368.74786Animal S50.716210.766356.4994749,808,765,1141,659,965.08930,005.91124Animal S60.765340.673507.7142851,955,834,5871,284,496.79540,448.39566Animal S70.759880.759886.3809548,488,087,9421,422,827.21934,078.69016Animal S80.745670.872444.9884243,521,230,9001,353,662.00732,150.73680Animal S90.732880.872135.6190449,005,799,9251,556,217.27131,490.33291Animal S100.718880.984875.1428550,650,821,1261,422,827.21935,598.71533  Ischemia groupC---NC RatioCortical Volume (ml)Vv\[Glom\] (%)Total glomerular volume (µm³)VWGV (µm³)N\[Glom\] (millions per kidney)Animal I10.697660.704634.5619032,144,958,1181,783,474.39618,023.78447Animal I20.690920.925834.0000037,033,390,7071,452,469.45325,496.84652Animal I30.717330.645604.0000025,824,003,3461,393,184.98518,535.94722Animal I40.677681.023303.9047639,957,625,4091,452,469.45327,510.13134Animal I50.652330.815414.5714237,276,064,5731,758,772.53421,194.36359Animal I60.715210.750973.7142827,893,249,9151,195,570.09423,330.50154Animal I70.709380.851264.0000034,050,483,2341,496,932.80322,746.83484Animal I80.669000.876393.8095233,386,406,3681,146,166.37129,128.76108Animal I90.6477840.816203.1428525,652,268,8401,343,781.26219,089.61641Animal I100.681020.803614.6666637,502,018,1201,338,840.89028,010.81025  Sham Resveratrol groupC-NC RatioCortical volume (ml)Vv\[Glom\] (%)Total glomerular volume (µm³)VWGV (µm³)N\[Glom\] (millions per kidney)Animal SR10.759650.866004.7619041,238,541,7891,778,534.02423,186.81636Animal SR20.730930.840574.0000033,622,988,7291,739,011.04519,334.54582Animal SR30.778380.840656.4761954,442,400,5571,363,542.75139,927.16803Animal SR40.755680.793464.9523839,295,526,9781,526,575.03725,740.97311Animal SR50.784120.980154.5714244,806,879,7081,862,520.35224,057.12219Animal SR60.796460.828327.3333360,743,904,7011,832,878.11933,141.26787Animal SR70.778450.941926.1904758,309,860,6591,561,157.64337,350.39887Animal SR80.785311.177965.6190466,190,601,6801,585,859.50441,737.99854Animal SR90.744941.117415.8095264,916,243,5361,566,098.01541,450.94554  Ischemia Resveratrol groupC---NC RatioCortical volume (ml)Vv\[Glom\] (%)Total glomerular volume (µm³)VWGV (µm³)N\[Glom\] (millions per kidney)Animal IR10.759200.751616.9523852,255,110,6441,674,786.20631,201.06344Animal IR20.707380.792276.3523850,328,361,8591,343,781.26237,452.79330Animal IR30.687770.900986.2095255,947,121,2931,501,873.17537,251.56172Animal IR40.677830.704946.7619047,667,778,4831,324,019.77336,002.31617Animal IR50.705870.656466.0952340,013,300,7931,704,428.43923,476.08141Animal IR60.748790.980926.0952359,789,779,9151,640,203.60036,452.65742Animal IR70.746470.858445.5238047,418,856,5771,422,827.21933,327.20653Animal IR80.736760.906215.3666648,633,737,1731,274,616.05038,155.59765Animal IR90.690820.828994.7619039,475,823,4981,773,593.65122,257.53541Animal IR100.704100.697056.0000041,823,540,0002,045,314.12720,448.46777

2. Experimental design, materials, and methods {#sec0002}
==============================================

All experiments were performed according to the national and international laws for scientific use of animals, and this project was formally approved by the local Ethics Committee for animal experimentation.

Male rats of Wistar lineage (*n* = 39; 9 weeks of age) were used, being allocated into 4 groups at random: Sham (S) -- group submitted to open laparotomy and dissection of the renal pedicle; Sham Resveratrol (SR) -- group previously treated with resveratrol and submitted to the same procedures of group Sham; Ischemia (I) - group submitted to 1-hour renal warm ischemia; Ischemia Resveratrol (IR) - group previously treated with resveratrol and submitted to 1-hour renal warm ischemia. Groups SR and IR received 30 mg/kg of resveratrol (Resveratrol, Terraternal, Santa Clara, USA) intraperitoneally 1 h before surgery, while untreated groups (S and I) received saline injections.

The animals were anesthetized via intramuscular ketamine (Cetamin, Syntec, Santana de Parnaíba, Brazil, 100 mg/kg) and xylazine (Xilazin, Syntec, 20 mg/kg). Once the surgical field was aseptic, a ventral midline incision was used to expose the abdominal viscera, which were displaced to expose the retroperitoneal area and the left kidney. The left renal artery and vein were isolated by blunt dissection. In rats of groups I and IR the renal vessels were clamped for 1 h, while in groups S and SR the pedicle was only dissected, and no ischemia was induced. All animals remained under anesthesia for 1 h, when the abdominal viscera were replaced, and the surgical wound was covered with moistened gauze. At the end of this period, vascular clamps were removed, and left kidney reperfusion was observed in groups I and IR. For all groups abdominal cavity was closed routinely.

The animals were killed a month after surgery by anesthetic overdose (Isoflurane, BioChimico, Rio de Janeiro, Brazil). A blood sample was collected by cardiac puncture during rats' anesthetic plan, so it was possible to determine urea and creatinine serum levels by biochemical analysis (automated enzymatic method).

Both kidneys were dissected, collected and weighed. The renal volume was measured by the Scherle\'s method [@bib0001],[@bib0002]. Left kidneys fixed in 4% buffered formaldehyde. The cortex-non-cortex areas ratio (C---NC) was achieved by morphometrical analysis of 2 mm transversal slices of left kidneys and calculated by the Cavalieri method [@bib0003], [@bib0004], [@bib0005]. The cortical volume (CV) was calculated by multiplying the renal volume by the C---NC [@bib0005].

Random samples from all 39 left kidneys were processed for paraffin embedding, sectioned at 5 µm thickness, and resulting histological blades were stained with haematoxylin and eosin. From each kidney, 25 histological fields, obtained from five different sections of the renal cortex, were photographed with a camera in a light microscope to be examined. Glomerular volumetric density (Vv\[G*lom*\]), which indicates the proportional volume occupied by the glomeruli in the cortex, was estimated by the point-counting method [@bib0003], [@bib0004], [@bib0005]. The volume-weighted mean glomerular volume (VWGV) was estimated by using the point-sampled intercepts method [@bib0003], [@bib0004], [@bib0005]. The estimation of the total number of glomeruli per kidney (N\[G*lom*\]) was achieved through the formula CVxVv\[G*lom*\]/VWGV [@bib0005].

Analyses were performed using GraphPad Prism 8.3.1 (GraphPad Software, San Diego, USA). The quantitative results were compared by one-way ANOVA with Tukey\'s post-test and all results were considered significant when the value of *p*\<0.05.
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